Cancer

MiBA Expands Support for Value-Based Cancer Care Through Partnership with American Oncology Network

Strategic collaboration with AON strengthens MiBA's mission to enable data-driven, value-based oncology care through real-world evidence, and technology integration. TAMPA,…

1 month ago

Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Clinical Trial has Advanced to Fifth and Final Cohort at Maximum Dose of INSTASYL PH-762 in Skin Cancer Trial Positive…

1 month ago

Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular…

1 month ago

Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular…

1 month ago

Impiricus Launches Ascend, An AI Platform To Ethically Connect Physicians And Pharma

Ascend sets a new standard in physician support through precision-tailored new resources to give patients faster, more reliable access to…

1 month ago

Strava and GoFundMe Team Up to Empower Athletes to Move “For a Cause”

New feature makes it easy for Strava users to raise awareness and funds for meaningful causes through activity SAN FRANCISCO,…

1 month ago

Embr Wave “personal thermostat” wearable now delivers temperature automatically

BOSTON, Nov. 13, 2025 /PRNewswire/ -- Embr Labs, Inc, makers of the Embr Wave Smart Cooling & Warming Wristband, have…

1 month ago

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™…

1 month ago

Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented

Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response…

1 month ago